Genenta Science Amends Services Agreement with AGC Biologics
Ticker: GNTA · Form: 6-K · Filed: Aug 1, 2025 · CIK: 1838716
| Field | Detail |
|---|---|
| Company | Genenta Science S.P.A. (GNTA) |
| Form Type | 6-K |
| Filed Date | Aug 1, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, services-agreement, biotech
TL;DR
Genenta Science inked a second amendment to its development deal with AGC Biologics on Dec 30, 2024.
AI Summary
On December 30, 2024, Genenta Science S.p.A. entered into the Second Amendment to its Development and Master Services Agreement with AGC Biologics S.p.A. This amendment modifies the terms of their existing agreement, which was originally effective March 6, 2019.
Why It Matters
This amendment to a key service agreement could impact Genenta's development timelines and manufacturing costs for its biological products.
Risk Assessment
Risk Level: low — The filing is a routine amendment to an existing service agreement and does not appear to introduce new significant risks.
Key Players & Entities
- Genenta Science S.p.A. (company) — Registrant
- AGC Biologics S.p.A. (company) — Counterparty to agreement
- December 30, 2024 (date) — Date of agreement amendment
- March 6, 2019 (date) — Original effective date of agreement
FAQ
What is the primary purpose of the Second Amendment to the Development and Master Services Agreement?
The filing indicates that the Second Amendment modifies the terms of the existing Development and Master Services Agreement between Genenta Science S.p.A. and AGC Biologics S.p.A.
Who are the parties involved in the Second Amendment?
The parties involved are Genenta Science S.p.A. and AGC Biologics S.p.A.
When was the Second Amendment entered into?
The Second Amendment was entered into on December 30, 2024.
What was the original effective date of the Development and Master Services Agreement?
The original Development and Master Services Agreement was effective as of March 6, 2019.
What type of company is Genenta Science S.p.A.?
Genenta Science S.p.A. is classified under the SIC code 2836 for Biological Products (No Diagnostic Substances).
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on August 1, 2025 regarding Genenta Science S.p.A. (GNTA).